Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A in situ carcinoma that involves the extrahepatic bile duct.
Biomarker and diagnostic research for carcinoma in situ of extrahepatic bile duct has been reported in the published literature.
No clinical trials have been registered for carcinoma in situ of extrahepatic bile duct.
8 publications have been identified in PubMed for carcinoma in situ of extrahepatic bile duct. Research spans Diagnostic / Biomarker (25%), Review / Meta-Analysis (25%), and Case Report / Case Series (25%).
Barsch M (2026). [PMID: 41535645](https://pubmed.ncbi.nlm.nih.gov/41535645/). *J Gastrointest Cancer*. [Review / Meta-Analysis]
Hirano S (2025). [PMID: 39805624](https://pubmed.ncbi.nlm.nih.gov/39805624/). *Nihon Shokakibyo Gakkai Zasshi*. [Review / Meta-Analysis]
Chen Y (2025). [PMID: 40854993](https://pubmed.ncbi.nlm.nih.gov/40854993/). *Surg Endosc*. [Epidemiology / Natural History]
Zeng LL (2025). [PMID: 40619266](https://pubmed.ncbi.nlm.nih.gov/40619266/). *Zhonghua Bing Li Xue Za Zhi*. [Basic Science / Preclinical]
Kiuchi R (2025). [PMID: 40657564](https://pubmed.ncbi.nlm.nih.gov/40657564/). *Surg Case Rep*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 9:49 PM UTC
Tamada H (2024). [PMID: 39198902](https://pubmed.ncbi.nlm.nih.gov/39198902/). *Diagn Pathol*. [Diagnostic / Biomarker]
Shirota Y (2024). [PMID: 39680512](https://pubmed.ncbi.nlm.nih.gov/39680512/). *Am J Case Rep*. [Case Report / Case Series]